APA (7th ed.) Citation

J, E., JP, B., B, S., S, R., & T, L. (2022). Reply to Potential Issues With the Use of Teriparatide After Denosumab-Related Osteonecrosis of the Jaw. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 37(10), 2046. https://doi.org/10.1002/jbmr.4656

Chicago Style (17th ed.) Citation

J, Everts-Graber, Burkhard JP, Schaller B, Reichenbach S, and Lehmann T. "Reply to Potential Issues With the Use of Teriparatide After Denosumab-Related Osteonecrosis of the Jaw." Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research 37, no. 10 (2022): 2046. https://doi.org/10.1002/jbmr.4656.

MLA (9th ed.) Citation

J, Everts-Graber, et al. "Reply to Potential Issues With the Use of Teriparatide After Denosumab-Related Osteonecrosis of the Jaw." Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research, vol. 37, no. 10, 2022, p. 2046, https://doi.org/10.1002/jbmr.4656.